The current valuation score of Takeda Pharmaceutical Co Ltd is 8.93, ranking 47 out of 156 in the Pharmaceuticals industry. Its current P/E ratio is 45.57, which is 430.63% below the recent high of 241.82 and 77.79% above the recent low of 10.12.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.